BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22764521)

  • 1. [The adjuvant effect of granulocyte macrophage colony stimulating factor (GM-CSF) in dengue virus and hepatitis C virus DNA vaccines].
    Wu JM; Chen H; Sheng ZY; Wang J; Fan DY; Gao N; An J
    Bing Du Xue Bao; 2012 May; 28(3):207-12. PubMed ID: 22764521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
    Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
    Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
    Zhai Y; Zhou Y; Li X; Feng G
    Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice.
    Chen H; Gao N; Fan D; Wu J; Zhu J; Li J; Wang J; Chen Y; An J
    PLoS One; 2012; 7(4):e34602. PubMed ID: 22493704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of adjuvant activities of glucosaminyl-muramyl dipeptide and of the gene coding for granulocyte-macrophage colony-stimulating factor in DNA immunization against herpes simplex virus].
    Kozlov AIu; Klimova RR; Shingarova LN; Boldyreva EF; Nekrasova OV; Gur'ianova SV; Andronova TM; Novikov VV; Kushch AA
    Mol Biol (Mosk); 2005; 39(3):504-12. PubMed ID: 15981580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
    APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cell-mediated immunity induced by intramuscular chitosan-pJME/ GM-CSF nano-DNA vaccine in BAlb/c mice].
    Zhai YZ; Zhou Y; Ma L; Feng GH
    Bing Du Xue Bao; 2014 Jul; 30(4):423-8. PubMed ID: 25272598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells.
    Ou-Yang P; Hwang LH; Tao MH; Chiang BL; Chen DS
    J Med Virol; 2002 Mar; 66(3):320-8. PubMed ID: 11793383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice.
    Zheng X; Chen H; Wang R; Fan D; Feng K; Gao N; An J
    Front Cell Infect Microbiol; 2017; 7():175. PubMed ID: 28553618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of GM-CSF and IL-5 as molecular adjuvants on immune responses and contraception induced by mZP3 DNA vaccination.
    Ma X; Kadir Z; Li J; Zhang F
    Am J Reprod Immunol; 2012 Dec; 68(6):476-85. PubMed ID: 22934542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
    Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
    Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.
    Encke J; Bernardin J; Geib J; Barbakadze G; Bujdoso R; Stremmel W
    World J Gastroenterol; 2006 Nov; 12(44):7118-25. PubMed ID: 17131473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
    Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
    Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen against dengue virus serotype 2 infection.
    Chen H; Zheng X; Wang R; Gao N; Sheng Z; Fan D; Feng K; Liao X; An J
    Clin Immunol; 2016 Oct; 171():41-49. PubMed ID: 27578400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.